The European Commission has approved the expansion of the use of UCB’s VIMPAT (lacosamide) to include monotherapy and adjunctive therapy of partial-onset (focal) seizures ... Read more
Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs). The ... Read more
The European Medicines Agency has scheduled an unprecedented public hearing in September on whether epilepsy therapies that contain sodium valproate pose a risk to pregnant women. ... Read more
A technique called MRI-guided laser interstitial thermal therapy (MgLiTT) may be a potential treatment for epilepsy patients, according to a recent ... Read more
The National Institutes of Health has awarded a $3.4 million grant to a Cleveland Clinic-led research collaboration whose objective is to come up ... Read more
Researchers studied the medical records of patients with drug-resistant focal epilepsy who underwent surgery for the disorder at the age of 50 ... Read more
An ultra-marathon cyclist with epilepsy has broken world indoor-track records for the longest distances covered in six and eight hours. Katie Ford ... Read more
The U.S. Food and Drug Administration (FDA) recently approved LivaNova’s VNS Therapy Systems for the treatment of drug-resistant partial onset epileptic ... Read more
The epilepsy therapy known as Zebinix in Europe and Aptiom in the United States does not impair cognition in children, a Phase ... Read more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more
